Zobrazeno 1 - 10
of 18
pro vyhledávání: '"G. Caleb Alexander"'
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories
Autor:
Ken Ogasawara, G. Caleb Alexander
Publikováno v:
Clinical Pharmacology in Drug Development. 8:914-921
Biologics, especially monoclonal antibodies, are increasingly important in the pharmaceutical marketplace. Population pharmacokinetic (PK) analyses could be useful to guide the need for dose adjustments among special populations, yet it is unknown ho
Publikováno v:
American Journal of Nephrology. 49:20-31
Background: Hemodialysis (HD) patients frequently experience pain. Previous studies of HD patients suggest increased opioid prescribing through 2010. It remains unclear if this trend continued after 2010 or declined with national trends. Methods: Lon
Tobacco control policies and smoking cessation treatment utilization: A moderated mediation analysis
Autor:
Joanna E. Cohen, Jon S. Vernick, Kira E. Riehm, Ramin Mojtabai, Johannes Thrul, G. Caleb Alexander
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0241512 (2021)
PLoS ONE, Vol 16, Iss 8, p e0241512 (2021)
Background Tobacco policies, including clean indoor air laws and cigarette taxes, increase smoking cessation in part by stimulating the use of cessation treatments. We explored whether the associations between tobacco policies and treatment use varie
Publikováno v:
Drug and alcohol dependence. 219
Background Evidence suggests that over 50 % of individuals who used prescription opioids non-medically obtained their prescription from friends or family. Despite its high consequence, reliable opioid diversion prevalence estimates are lacking due to
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
BMC Medicine
BMC Medicine
Background Previous studies on high-risk opioid use have only focused on patients diagnosed with an opioid disorder. This study evaluates the impact of various high-risk prescription opioid use groups on healthcare costs and utilization. Methods This
Autor:
Jeremy A. Greene, Joshua M. Sharfstein, Taruja D Karmarkar, Antonio J. Trujillo, Gerard F. Anderson, Jeromie Ballreich, Mariana P. Socal, G. Caleb Alexander
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:1469-1478
The high prices of specialty pharmaceuticals are causing some public programs to ration care and many private insurers, including Medicare drug plans, to place specialty drugs on high cost-sharing tiers. As a result, access to these drugs is often re
Publikováno v:
Medical Care. 55:669-676
BACKGROUND: Buprenorphine-naloxone treatment for opioid use disorder has rapidly expanded, yet little is known about treatment outcomes among patients in the general population. OBJECTIVE: To examine predictors of treatment duration, dosage, and cont
Autor:
Shoshana H. Ballew, Morgan E. Grams, Tessa K. Novick, Lesley A. Inker, Jung Im Shin, Aditya Surapaneni, G. Caleb Alexander, Alex R. Chang
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 13(12)
Over 60% of individuals with CKD have chronic pain, a prevalence two to three times that of the general population ([1][1]). Although the pharmacologic treatment of pain among individuals with normal kidney function is often challenging, pain managem
Publikováno v:
Pediatrics. 142
BACKGROUND AND OBJECTIVES: Information on the use of prescription medications among children and adolescents in the United States is lacking. We estimate the prevalence of prescription medication use, concurrent use, and potential major drug–drug i